
T cells are positioned at the frontline of the body’s immune system to fight infection, cancer, and autoimmune disease. While different subtypes of T cells exist, how these cells take their different forms has remained elusive.
Now, a multi-institutional team of researchers led by Yale School of Medicine (YSM) has added clarity to the complex, dynamic molecular interactions that occur in the human immune system. In a new study, the researchers have identified one of the levers that controls the fate of T cells and what subtype they transform into. Their findings were published recently in the journal Science.
“Researchers often think of T cells as falling into different buckets—T cells for infection or T cells for cancer or autoimmunity,” said Nikhil Joshi, PhD, associate professor of immunology at YSM and senior author of the study. “We want to have a more holistic view of this process. T cells all start at the same place, and we wanted to understand the rules that control how T cells change in response to the molecular signals they see as they mount a defense.”
(more…)

